Business Description
Apotea AB (publ)
ISIN : SE0023313762
Total Employee Number:
744Compare
Compare
Traded in other countries / regions
APOTEA.SwedenV30.GermanyAPOTEs.UK IPO Date
2024-12-12Description
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.36 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | 0.6 | |||||
Interest Coverage | 25.81 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 8.34 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.8 | |||||
3-Year EBITDA Growth Rate | 64.2 | |||||
3-Year EPS without NRI Growth Rate | 96.5 | |||||
3-Year Book Growth Rate | 37.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 23.18 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.03 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.04 | |||||
9-Day RSI | 47.47 | |||||
14-Day RSI | 48.81 | |||||
3-1 Month Momentum % | 16.37 | |||||
6-1 Month Momentum % | -17.78 | |||||
12-1 Month Momentum % | -16.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 0.56 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 47.08 | |||||
Days Sales Outstanding | 17.81 | |||||
Days Payable | 46.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.82 | |||||
Forward Dividend Yield % | 0.82 | |||||
5-Year Yield-on-Cost % | 0.81 | |||||
Shareholder Yield % | 0.19 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.07 | |||||
Operating Margin % | 4.16 | |||||
Net Margin % | 3.2 | |||||
EBITDA Margin % | 6.65 | |||||
FCF Margin % | 3.01 | |||||
OCF Margin % | 4.35 | |||||
ROE % | 29.24 | |||||
ROA % | 11.4 | |||||
ROIC % | 18.76 | |||||
3-Year ROIIC % | 39.06 | |||||
ROC (Joel Greenblatt) % | 32.3 | |||||
ROCE % | 28.89 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 33.08 | |||||
PE Ratio without NRI | 33.08 | |||||
PS Ratio | 1.07 | |||||
PB Ratio | 8.45 | |||||
Price-to-Tangible-Book | 8.91 | |||||
Price-to-Free-Cash-Flow | 35.09 | |||||
Price-to-Operating-Cash-Flow | 24.26 | |||||
EV-to-EBIT | 25.68 | |||||
EV-to-EBITDA | 16.25 | |||||
EV-to-Revenue | 1.08 | |||||
EV-to-FCF | 37.12 | |||||
Price-to-Graham-Number | 3.62 | |||||
| Price-to-Net-Current-Asset-Value | 67.7 | |||||
Earnings Yield (Greenblatt) % | 3.89 | |||||
FCF Yield % | 2.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apotea AB (publ) Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 676.9 | ||
| EPS (TTM) (€) | 0.209 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 59.28 | ||
| 14-Day RSI | 48.81 | ||
| 14-Day ATR (€) | 0.168834 | ||
| 20-Day SMA (€) | 6.77225 | ||
| 12-1 Month Momentum % | -16.44 | ||
| 52-Week Range (€) | 5.024 - 10.696 | ||
| Shares Outstanding (Mil) | 104.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apotea AB (publ) Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apotea AB (publ) Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-05 07:30 | In 118 days | ||
| Second quarter earnings results for 2026 | 2026-07-17 07:30 | In 7 days | ||
| SEK 0.600000 Cash Dividend | 2026-05-27 | 7.11 (-0.35%) | ||
| General meeting for 2026 | 2026-05-26 10:00 | 7.16 (+2.07%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 6.15 (+1.74%) | ||
| Annual report for 2025 | 2026-04-17 | 6.18 (+2.49%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-04 | 5.59 (-2.88%) | ||
| Third quarter earnings results for 2025 | 2025-11-06 | 7.39 (+1.68%) | ||
| Second quarter earnings results for 2025 | 2025-07-18 | 8.48 (+3.85%) | ||
| General meeting for 2025 | 2025-05-28 10:00 | 8.78 (-1.85%) |
Show
Entries
Apotea AB (publ) Frequently Asked Questions
What is Apotea AB (publ)(STU:V30)'s stock price today?
The current price of STU:V30 is €6.77. The 52 week high of STU:V30 is €10.70 and 52 week low is €5.02.
When is next earnings date of Apotea AB (publ)(STU:V30)?
The next earnings date of Apotea AB (publ)(STU:V30) is 2026-07-17.
Does Apotea AB (publ)(STU:V30) pay dividends? If so, how much?
The Dividend Yield %  of Apotea AB (publ)(STU:V30) is 0.82% (As of Today), Highest Dividend Payout Ratio of Apotea AB (publ)(STU:V30) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Apotea AB (publ)(STU:V30) is 0.82%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Apotea AB (publ)
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers